Literature DB >> 19476383

Morphology and secondary structure of stable beta-oligomers formed by amyloid peptide PrP(106-126).

Patrick Walsh1, Jason Yau, Karen Simonetti, Simon Sharpe.   

Abstract

The formation of nonfibrillar oligomers has been proposed to be a common element of the aggregation pathway of amyloid peptides. Here we describe the first detailed investigation of the morphology and secondary structure of stable oligomers formed by a peptide comprising residues 106-126 of the human prion protein (PrP). These oligomers have an apparent hydrodynamic radius of approximately 30 nm and are more membrane-active than monomeric or fibrillar PrP(106-126). Circular dichroism and solid state NMR data support formation of an extended beta-strand by the hydrophobic core of PrP(106-126), while negative thioflavin-T binding implies an absence of cross-beta structure in nonfibrillar oligomers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19476383     DOI: 10.1021/bi9007319

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  An oligomeric equilibrium intermediate as the precursory nucleus of globular and fibrillar supramacromolecular assemblies in a PDZ domain.

Authors:  Javier Murciano-Calles; Eva S Cobos; Pedro L Mateo; Ana Camara-Artigas; Jose C Martinez
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

2.  Human serum albumin inhibits Abeta fibrillization through a "monomer-competitor" mechanism.

Authors:  Julijana Milojevic; Annie Raditsis; Giuseppe Melacini
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

3.  Computer simulation study of amyloid fibril formation by palindromic sequences in prion peptides.

Authors:  Victoria A Wagoner; Mookyung Cheon; Iksoo Chang; Carol K Hall
Journal:  Proteins       Date:  2011-05-09

4.  Membrane Disruption Mechanism of a Prion Peptide (106-126) Investigated by Atomic Force Microscopy, Raman and Electron Paramagnetic Resonance Spectroscopy.

Authors:  Jianjun Pan; Prasana K Sahoo; Annalisa Dalzini; Zahra Hayati; Chinta M Aryal; Peng Teng; Jianfeng Cai; Humberto Rodriguez Gutierrez; Likai Song
Journal:  J Phys Chem B       Date:  2017-05-10       Impact factor: 2.991

5.  Copper chelating cyclic peptidomimetic inhibits Aβ fibrillogenesis.

Authors:  Sujan Kalita; Sourav Kalita; Altaf Hussain Kawa; Sukesh Shill; Anjali Gupta; Sachin Kumar; Bhubaneswar Mandal
Journal:  RSC Med Chem       Date:  2022-05-09

6.  The mechanism of membrane disruption by cytotoxic amyloid oligomers formed by prion protein(106-126) is dependent on bilayer composition.

Authors:  Patrick Walsh; Gillian Vanderlee; Jason Yau; Jody Campeau; Valerie L Sim; Christopher M Yip; Simon Sharpe
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

7.  Gold complexes inhibit the aggregation of prion neuropeptides.

Authors:  Xuesong Wang; Lei He; Cong Zhao; Weihong Du; Jun Lin
Journal:  J Biol Inorg Chem       Date:  2013-08-28       Impact factor: 3.358

8.  Infection of prions and treatment of PrP106-126 alter the endogenous status of protein 14-3-3 and trigger the mitochondrial apoptosis possibly via activating Bax pathway.

Authors:  Qi Shi; Qin-Qin Song; Peng Sun; Jin Zhang; Juan Song; Li-Na Chen; Kang Xiao; Shao-Bin Wang; Ya-Zhou Zhang; Gong-Qi Li; Lin-Jun Sheng; Bao-Dong Wang; Ming-Zhi Lu; Jun Han; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2013-10-18       Impact factor: 5.590

9.  Structural diversity and initial oligomerization of PrP106-126 studied by replica-exchange and conventional molecular dynamics simulations.

Authors:  Lulu Ning; Jingjing Guo; Qifeng Bai; Nengzhi Jin; Huanxiang Liu; Xiaojun Yao
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.